Literature DB >> 6529528

The effect of posture at the time of administration on the central depressant effects of the new hypnotic zopiclone.

K S Channer, M Dent, C J Roberts.   

Abstract

Nine healthy volunteers swallowed 7.5 mg zopiclone in the standing and lying positions on different occasions. Plasma concentrations of zopiclone and psychometric tests, including simple and complex reaction time, and critical flicker fusion threshold, were performed at regular intervals after drug administration. The results show that when the drug was swallowed in the supine position, there was a significant delay in the onset of the impairment of psychomotor function, with prolongation in time to peak impairment by 30-40 min (P less than 0.02). The overall impairment in psychomotor performance was found to be significantly less after administration of the drug in the supine position (P less than 0.005). Pharmacokinetic analysis revealed a prolongation in lag time of greater than 20 min before absorption began (P less than 0.002) after supine drug administration, with a significantly lower rate constant of absorption (P less than 0.02). Area under the plasma concentration-time curve extrapolated to infinity and rate constant of elimination were not significantly different between the two modes of administration. We conclude that to obtain a rapid and complete effect from the hypnotic zopiclone, the tablet should be swallowed in the standing position.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6529528      PMCID: PMC1463687          DOI: 10.1111/j.1365-2125.1984.tb02559.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  5 in total

1.  Oesophageal transit of six commonly used tablets and capsules.

Authors:  H Hey; F Jørgensen; K Sørensen; H Hasselbalch; T Wamberg
Journal:  Br Med J (Clin Res Ed)       Date:  1982-12-11

2.  Effect of posture and drink volume on the swallowing of capsules.

Authors:  K S Channer; J Virjee
Journal:  Br Med J (Clin Res Ed)       Date:  1982-12-11

3.  Antipyrine absorption after delayed oesophageal capsule transit.

Authors:  K S Channer; C J Roberts
Journal:  Br J Clin Pharmacol       Date:  1984-08       Impact factor: 4.335

4.  ESTRIP, a BASIC computer program for obtaining initial polyexponential parameter estimates.

Authors:  R D Brown; J E Manno
Journal:  J Pharm Sci       Date:  1978-12       Impact factor: 3.534

5.  Plasma concentrations and central nervous system effects of the new hypnotic agent zopiclone in patients with chronic liver disease.

Authors:  G Parker; C J Roberts
Journal:  Br J Clin Pharmacol       Date:  1983-09       Impact factor: 4.335

  5 in total
  5 in total

1.  In support of nitrate ointment for patients with acute myocardial infarction.

Authors:  K S Channer
Journal:  Postgrad Med J       Date:  1993-01       Impact factor: 2.401

2.  The excretion of zopiclone into breast milk.

Authors:  I Matheson; H A Sande; J Gaillot
Journal:  Br J Clin Pharmacol       Date:  1990-08       Impact factor: 4.335

Review 3.  Clinical pharmacokinetics of zopiclone.

Authors:  C Fernandez; C Martin; F Gimenez; R Farinotti
Journal:  Clin Pharmacokinet       Date:  1995-12       Impact factor: 6.447

Review 4.  Zopiclone. A review of its pharmacological properties and therapeutic efficacy as an hypnotic.

Authors:  A N Wadworth; D McTavish
Journal:  Drugs Aging       Date:  1993 Sep-Oct       Impact factor: 3.923

Review 5.  Zopiclone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy as an hypnotic.

Authors:  K L Goa; R C Heel
Journal:  Drugs       Date:  1986-07       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.